Healio

BLOG: CXL most effective choice for pediatric keratoconus

Please provide your email address to receive an email when new articles are posted on . Pediatric keratoconus is often an undiagnosed condition that results in many cases being untreated. As this ...
Medscape

Corneal Collagen Crosslinking Using UVA Light and Riboflavin for Keratoconus

Expert Rev Ophthalmol. 2012;7(1):33-44. mpared with preoperative data. Analysis of central corneal thickness, corneal volume, foveal thickness and retinal nerve fiber layer did not show a ...
Medscape

Does Crosslinking Reduce the Need for Corneal Transplants for Keratoconus? It's Too Soon to Tell

Corneal collagen crosslinking (CXL) with riboflavin and ultraviolet A light is a procedure that has been widely available around the world for about 5-10 years. Although it has many uses, including ...
Healio

Delayed CXL due to COVID-19 restrictions led to high rate of keratoconus progression

Please provide your email address to receive an email when new articles are posted on . Patients with keratoconus who had corneal cross-linking treatment delayed due to re-prioritization of services ...
Ophthalmology Times

Phase 3 data show Epioxa improves corneal curvature and vision in pediatric keratoconus

A pediatric subgroup from a pivotal phase 3 trial randomized 2:1 showed epithelium-on oxygen-enriched CXL improved Kmax at 6 ...
Nature

Effects and adverse events after CXL for keratoconus are independent of age: a 1-year follow-up study

To compare the effect, failure rate and the risks of corneal cross-linking (CXL) in keratoconus patients aged ≥35 years to patients <35 years. The aim of this study was to investigate the effect of ...
Monthly Prescribing Reference

Novel Corneal Cross-Linking Therapy Epioxa Approved for Keratoconus

Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.
Business Wire

CXL Ophthalmics Publishes Results of EpiSmart® Cross-Linking Phase 2 Clinical Trial for Keratoconus in Cornea

SHERBORN, Mass.--(BUSINESS WIRE)--CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today published results of the EpiSmart cross-linking Phase ...
Nature

Comparative study of long-term outcomes of accelerated and conventional collagen crosslinking for progressive keratoconus

Comparative clinical study of consecutive progressive keratoconic eyes that underwent either accelerated CXL (9 mW/cm 2 ultraviolet A (UVA) light irradiance for 10 min) or conventional CXL (3 mW/cm 2 ...
Philadelphia Mag

Good News for Patients with a Common Cornea Problem

Keratoconus is a progressive eye disorder affecting the cornea. While there is no cure as of yet, research is currently underway to slow its progression. “It is exciting because it is the first time ...
National Institute for Health and Care Excellence

Photochemical corneal collagen cross‑linkage using riboflavin and ultraviolet A for keratoconus and keratectasia

Most of the published evidence on photochemical corneal collagen cross‑linkage (CXL) using riboflavin and ultraviolet A (UVA) for keratoconus and keratectasia relates to the technique known as ...